(PharmaNewsWire.Com, May 27, 2017 ) A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).
Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.
According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 – 2022, chiefly driven by increasing spending over various immunization programmes.
The report titled “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.
Scope of the Report
Global Influenza Market (Actual Period: 2012-2016E, Forecast Period: 2017-2022) By Segment Type: Influenza Vaccine Market, Influenza Drugs Market By Vaccine Type: Trivalent, Quadrivalent By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir
Regional Markets – North America, Europe, APAC, RoW (Actual Period: 2012-2016E, Forecast Period: 2017-2022) By Segment Type: Influenza Vaccine Market, Influenza Drugs Market By Vaccine Type: Trivalent, Quadrivalent By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir
Country Analysis - US, Canada, UK, Germany, France, Japan, China, India (Actual Period: 2012-2016E, Forecast Period: 2017-2022) By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
Other Report Highlights • Market Dynamics – Trends, Drivers, Challenges • Pipeline Analysis • Company Analysis - Falvogen, Gilead Science and Bio Cryst
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
